Literature DB >> 9821992

Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.

J R Balser1, E A Martinez, B D Winters, P W Perdue, A W Clarke, W Huang, G F Tomaselli, T Dorman, K Campbell, P Lipsett, M J Breslow, B A Rosenfeld.   

Abstract

BACKGROUND: Postoperative supraventricular tachyarrhythmia is a common complication of surgery. Because chemical cardioversion is often ineffective, ventricular rate control remains a principal goal of therapy. The authors hypothesized that patients with supraventricular tachyarrhythmia after major noncardiac surgery who receive intravenous beta-adrenergic blockade for ventricular rate control would experience conversion to sinus rhythm at a rate that differs from those receiving intravenous calcium channel blockade.
METHODS: The rate of conversion to sinus rhythm at 2 and 12 h after treatment was examined in 64 cases of postoperative supraventricular tachyarrhythmia. After adenosine administration, patients who remained in supraventricular tachyarrhythmia were prospectively randomized to receive either intravenous diltiazem or intravenous esmolol for ventricular rate control (unblinded). Loading and infusion rates were adjusted to achieve equivalent degrees of ventricular rate control.
RESULTS: Patients were similar with regard to age and Apache III score. Most patients in both groups had atrial fibrillation (esmolol, 79%; diltiazem, 81%), and none experienced stable conversion with adenosine. Patients randomized to receive esmolol experienced a 59% rate of conversion to sinus rhythm within 2 h of treatment, compared with only 33% for patients randomized to receive diltiazem (intention to treat, P = 0.049; odds ratio, 2.9; 95% confidence interval, 1.046 to 7.8). After 12 h of therapy, the number of patients converting to sinus rhythm increased in both groups (esmolol, 85%; diltiazem, 62%), and the rates of conversion no longer differed significantly. Ventricular rates when supraventricular tachyarrhythmia began and after 2 and 12 h of rate control therapy were similar in the two treatment groups. The in-hospital mortality rate and length of stay in the intensive care unit were not significantly influenced by treatment group.
CONCLUSIONS: Among adenosine-resistant patients in the intensive care unit with atrial fibrillation after noncardiac surgery, intravenous esmolol produced a more rapid (2-h) conversion to sinus rhythm than did intravenous diltiazem.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821992     DOI: 10.1097/00000542-199811000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  24 in total

1.  Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.

Authors:  Allan J Walkey; Stephen R Evans; Michael R Winter; Emelia J Benjamin
Journal:  Chest       Date:  2016-01-06       Impact factor: 9.410

Review 2.  A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery.

Authors:  Heather Smith; Ching Yeung; Stephen Gowing; Mouhannad Sadek; Donna Maziak; Sebastien Gilbert; Farid Shamji; Patrick Villeneuve; Sudhir Sundaresan; Andrew Seely
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

3.  Use of landiolol in the perioperative management of supraventricular tachycardia.

Authors:  Hiroaki Ito; Kazuya Sobue; Minhye So; Hiroyuki Hirate; Takeshi Sugiura; Takafumi Azami; Hiroshi Sasano; Hirotada Katsuya
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 4.  [Preoperative risk evaluation in heart failure].

Authors:  B Cremers; C Maack; M Böhm
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

Review 5.  New-onset atrial fibrillation in adult critically ill patients: a scoping review.

Authors:  Mik Wetterslev; Nicolai Haase; Christian Hassager; Emilie P Belley-Cote; William F McIntyre; Youzhong An; Jiawei Shen; Alexandre Biasi Cavalcanti; Fernando G Zampieri; Helio Penna Guimaraes; Anders Granholm; Anders Perner; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2019-05-14       Impact factor: 17.440

6.  Rhythm is a dancer: the immediate management of postoperative atrial fibrillation following cardiac surgery.

Authors:  Martin I Sigurdsson; Simon C Body
Journal:  Ann Transl Med       Date:  2016-10

7.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 8.  Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.

Authors:  Vivencio Barrios; Carlos Escobar
Journal:  J Atr Fibrillation       Date:  2011-12-20

Review 9.  New-onset atrial fibrillation in critically ill patients.

Authors:  Stephanie Sibley; John Muscedere
Journal:  Can Respir J       Date:  2015 May-Jun       Impact factor: 2.409

10.  Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data.

Authors:  Ari Moskowitz; Kenneth P Chen; Avraham Z Cooper; Abdullah Chahin; Mohammad M Ghassemi; Leo Anthony Celi
Journal:  Shock       Date:  2017-10       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.